Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids

Mycoses

Volumn 56, Issue 6, 2013, Pages 623-630

  Tobudic, Selma ^a   Forstner, Christina ^a   Schranz, Heidelinde ^a   Poeppl, Wolfgang ^a   Vychytil, Andreas ^a   Burgmann, Heinz ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Candida albicans; Fungicidal activity; Intraperitoneal administration

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; MICAFUNGIN; PERITONEAL DIALYSIS FLUID;

ARTICLE; CANDIDA ALBICANS; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; GROWTH INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

CANDIDA ALBICANS; FUNGI;

CANDIDA ALBICANS; FUNGICIDAL ACTIVITY; INTRAPERITONEAL ADMINISTRATION;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DIALYSIS SOLUTIONS; ECHINOCANDINS; HUMANS; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PERITONEAL DIALYSIS; TIME FACTORS;

EID: 84886281626     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12079     Document Type: Article

References (24)

1. Piraino B, Bailie GR, Bernardini J et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107-31.
2. Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25: 274-84.
3. Fried L, Abidi S, Bernardini J, Johnston JR, Piraino B. Hospitalization in peritoneal dialysis patients. Am J Kidney Dis 1999; 33: 927-33.
4. Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2176-82.
5. Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 2002; 39: 1278-86.
6. Bibashi E, Memmos D, Kokolina E, Tsakiris D, Sofianou D, Papadimitriou M. Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases. Clin Infect Dis 2003; 36: 927-31.
7. Ram R, Swarnalatha G, Neela P, Murty KV. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single-centre experience in India. Nephron Clin Pract 2008; 110: c207-12.
8. Goldie SJ, Kiernan-Tridle L, Torres C et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28: 86-91.
9. Miles R, Hawley CM, McDonald SP et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009; 76: 622-8.
10. Das R, Vaux E, Barker L, Naik R. Fungal peritonitis complicating peritoneal dialysis: report of 18 cases and analysis of outcomes. Adv Perit Dial 2006; 22: 55-9.
11. Li PK, Szeto CC, Piraino B et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010; 30: 393-423.
12. Piraino B. Peritoneal dialysis infections recommendations. Contrib Nephrol 2006; 150: 181-6.
13. Cozens RM, Tuomanen E, Tosch W, Zak O, Suter J, Tomasz A. Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrob Agents Chemother 1986; 29: 797-802.
14. Tuomanen E, Cozens R, Tosch W, Zak O, Tomasz A. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol 1986; 132: 1297-304.
15. Arendrup MC, Cuenca-Estrella M, Lass-Florl C, Hope W. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). Clin Microbiol Infect 2012; 18: E246-7.
16. Shalit I, Welch DF, San Joaquin VH, Marks MI. In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother 1985; 27: 908-11.
17. Zelenitsky S, Barns L, Findlay I et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36: 1009-13.
18. Xu G, Tu W, Xu C. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2010; 25: 587-92.
19. de Vin F, Rutherford P, Faict D. Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use. Perit Dial Int 2009; 29: 5-15.
20. Tobudic S, Poeppl W, Kratzer C, Vychytil A, Burgmann H. Comparative in vitro antimicrobial activity of vancomycin, teicoplanin, daptomycin and ceftobiprole in four different peritoneal dialysis fluids. Eur J Clin Microbiol Infect Dis 2012; 31: 1327-34.
21. Madariaga MG, Tenorio A, Proia L. Trichosporon inkin peritonitis treated with caspofungin. J Clin Microbiol 2003; 41: 5827-9.
22. Fourtounas C, Marangos M, Kalliakmani P, Savidaki E, Goumenos DS, Vlachojannis JG. Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy. Nephrol Dial Transplant 2006; 21: 236-7.
23. Molina P, Puchades MJ, Aparicio M, Garcia Ramon R, Miguel A. [Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases]. Nefrologia 2005; 25: 393-8.
24. Hashimoto H, Moriya R, Kamata K, Higashihara M, Yoshida K, Kume H. [Successful treatment with micafungin (MCFG) of severe peritonitis due to Candida parapsilosis with chronic renal failure patient on hemodialysis]. Kansenshogaku Zasshi 2005; 79: 195-200.